Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.
about
The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factorsBACH1 Ser919Pro variant and breast cancer risk.TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.The LIM and SH3 domain protein family: structural proteins or signal transducers or both?Multivariate Boosting for Integrative Analysis of High-Dimensional Cancer Genomic Data.Pathway-BasedFeature Selection Algorithm for Cancer Microarray Data.Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17.Chromosome 17 centromere duplication and responsiveness to anthracycline-based neoadjuvant chemotherapy in breast cancer.Comprehensive copy number profiles of breast cancer cell model genomes.Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.Array-CGH and breast cancer.Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.Functional characterization of the 19q12 amplicon in grade III breast cancersHER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1qHapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.DNA amplifications in breast cancer: genotypic-phenotypic correlations.Wip1 phosphatase in breast cancer.WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206.The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion.Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.Discovery of Small Molecule Inhibitors that Interact with γ-Tubulin
P2860
Q24304594-61263413-ABE7-4FDE-9144-F6DB98404FD5Q25257890-30ED3EDF-7012-4B0C-A422-E21EF01BC994Q27330524-3E7284E1-B45B-4820-B971-B06CA68BD3E1Q30157698-F6907B7A-442C-473E-83AF-B45BFDB7AC8DQ31028324-871CEA5E-0224-4FFA-B0C5-C1B5B7062BCAQ33537191-D5184EA6-FF07-4340-835E-90A16574A3F3Q33670486-35E97D8C-CCBD-4A57-AE93-8F89B529972DQ33674682-B67B3D6F-3BD8-443D-9F6D-A1A3F0724928Q33780945-29B52AAF-69C3-420E-86F9-18722675AA8CQ34080017-F59F627D-AC8B-48E3-B3AA-E701FC49518DQ34417532-6D5FB4FF-FCB3-41CF-8FC4-E9F9090DF162Q34480698-5252CDCF-34F4-4ECE-B762-8817994CA6DBQ34760593-41DC7F45-5392-4DF5-8876-BDF25E71E20DQ35012854-A960FE80-BAD2-473C-A1CE-4A3892D125E6Q35029573-5EC1D407-0739-48F9-AD8A-F9AB47E5712BQ35496577-D6E0678E-9AF3-4D0B-93D5-30441A2A0B1EQ35848430-D567CE77-3A69-4F7D-80DC-5C8800522043Q36245567-4D7793C9-CEF6-4F29-9A9C-83ABD4FD28C4Q36609893-F9A0EE62-469B-4BB7-A1CF-4295D1FD7B2FQ36612025-E83F0B00-642A-4784-9EC8-670AA995AE94Q36612585-202C61B6-AFE0-46FC-8EF3-A54E93548D04Q36629194-8B0F8551-FB1D-4C69-8A8F-1DDD94671409Q37570230-7FD90E0D-90E8-4560-BF65-898FB46D6971Q37763102-DA845684-3A1E-4734-9003-2E46142C2BD1Q38266298-BC4DF15B-86ED-4588-9349-B3504AF794CCQ38708424-804BF110-94B8-4279-9812-C81344D75085Q38945828-30628AE8-D3A5-40DA-AE7F-EB727394E257Q40572097-D1D53BFC-4A4C-4E35-9846-42F52362D95EQ41133771-85B7C10E-E3B7-4273-B9E6-5361CDA7F468Q57014309-B8DF2544-B0B8-43BB-8855-F33D21B7D808
P2860
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genomic and expression profili ...... ons and novel candidate genes.
@en
type
label
Genomic and expression profili ...... ons and novel candidate genes.
@en
prefLabel
Genomic and expression profili ...... ons and novel candidate genes.
@en
P2093
P50
P1433
P1476
Genomic and expression profili ...... ons and novel candidate genes.
@en
P2093
Béatrice Orsetti
Carmen Rodriguez
Catherine Nguyen
Laurence Lasorsa
Lisa Ursule
Mélanie Nugoli
Nathalie Cervera
Paul Chuchana
P304
P356
10.1158/0008-5472.CAN-04-0756
P407
P577
2004-09-01T00:00:00Z